If you or someone you care about is facing severe colorectal cancer, a new clinical trial might catch your interest. This study is exploring the effectiveness of a drug called SHR-1701 when used alongside chemotherapy and radiation. Participants will first receive SHR-1701 with a chemotherapy regimen for one cycle, followed by a short course of radiation. After this, they will continue with SHR-1701 and chemotherapy for several more cycles before undergoing surgery. The goal is to see if this combination leads to a complete response in the cancer before surgery, which could mean better outcomes for patients. With 48 participants expected, this trial aims to shed light on a promising treatment approach for those battling this tough disease.
Phase 2 Trial: SHR-1701 Plus Chemoradiotherapy for Advanced Rectal CancerCould a new drug boost treatment for severe colorectal cancer?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Evaluate SHR-1701 with chemoradiotherapy for pCR in severe CRC in a Phase 2 trial.
This Phase 2 clinical trial aims to assess the efficacy of neoadjuvant SHR-1701 combined with chemoradiotherapy in treating severe colorectal cancer (CRC). The study is currently recruiting with an estimated enrollment of 48 participants. The treatment regimen includes an induction phase with SHR-1701 and CAPOX, followed by short-course radiotherapy (SCRT), and a consolidation phase with the same drug combination. The induction phase involves a single cycle of SHR-1701 at 30 mg/kg and CAPOX, consisting of oxaliplatin at 130 mg/m² and capecitabine at 1000 mg/m². Radiotherapy is administered as 25 Gy in 5 fractions over 5 consecutive days. The consolidation phase continues with SHR-1701 and CAPOX for five cycles. The primary outcome measure is the pathological complete response (pCR). The trial is sponsored by Hong Qiu, with a start date of December 20, 2025, and an expected primary completion date of December 31, 2027.
What this means for you:
SHR-1701 may enhance treatment effectiveness for severe colorectal cancer before surgery. More on Cancer
Comprehensive palliative care improves quality of life, survival, and symptoms in thoracic cancer patients
Palliative care improves quality of life for thoracic cancer patients
This meta-analysis of 6490 people with thoracic cancer found that comprehensive palliative care interventions improved quality of life (SMD …
Comprehensive palliative care can improve survival, manage symptoms, and boost quality of life for people living with thoracic cancers.
Long-read sequencing improves detection of structural variants and methylation patterns in liquid biopsy
Long-read sequencing improves detection of cancer signals in blood
This mini-review examines the application of long-read sequencing (LRS) for liquid biopsy, specifically focusing on cfDNA and ctDNA. The aut…
Newer long-read sequencing technology helps doctors identify complex genetic changes and the source of tumors in lung, brain, and pediatric …
EMR integrated platform improves data abstraction efficiency and speed for cancer patient records
New digital platform speeds up cancer data collection and entry
Researchers evaluated an EMR-integrated platform designed to automate data extraction from cancer patient records. The study found that the …
A new software tool cut the time needed to record cancer treatment details by nearly half, helping medical teams work faster.
Artificial intelligence as a mechanistic microscope and digital twin in colorectal cancer faces generalizability and regulatory validation limitations
Artificial intelligence acts as a digital microscope for colorectal cancer patients
This narrative review discusses the use of artificial intelligence as a mechanistic microscope and digital twin for patients with colorectal…
A review explores how artificial intelligence could help doctors see colorectal cancer better, though more testing is needed before patients…
View Original Abstract ↓
Status: RECRUITING | Phase: PHASE2
Condition(s): CRC (Colorectal Cancer)
Intervention(s): SHR-1701 neoadjuvant (DRUG)
The goal of this clinical trial is to learn if SHR-1701 combine with chemoradiotherapy works to treat severe CRC.
Participants will take:
Induction: SHR-1701 combined with CAPOX for one cycle. Radiotherapy: Short-course radiotherapy (SCRT) (25Gy/5F). Consolidation: SHR-1701 combined with CAPOX for five cycles, after which the subjects undergo TME surgery.
Detailed: 1. Induction Phase SHR-1701: Intravenous infusion at a fixed dose of 30 mg/kg, depending on the protocol), administered on Day 1.
CAPOX Regimen:
Oxaliplatin: 130 mg/m², intravenous infusion on Day 1;
Capecitabine: 1000 mg/m², orally twice daily from Day 1 to Day 14, followed by 7 days of rest.
This phase consists of 1 cycle (each cycle is 21 days).
2. Radiotherapy
Short-course radiotherapy (SCRT) will be initiated shortly after the induction phase:
Total dose: 25 Gy delivered in 5 fractions of 5 Gy each, administered on 5 consecutive days .
3. Consolidation Phase
Following radiotherapy, participants will continue treatment with SHR-1701 combined with CAPOX:
SHR-1701: Same dose as induction, administered every 3 weeks (Day 1 of each cycle).
CAPOX: Same re
Primary Outcome(s): pCR
Enrollment: 48 (ESTIMATED)
Lead Sponsor: Hong Qiu
Start: 2025-12-20 | Primary Completion: 2027-12-31
Higher TyG Index Linked to 4.36-Fold Increased Odds of NAFLD in Large Meta-Analysis
TyG Index Linked to Higher Fatty Liver Risk
Related in Gastroenterology
Acupuncture modulates the microbiota-gut-brain axis to remodel microbial structure in patients with irritable bowel syndrome
Acupuncture May Help Manage Irritable Bowel Syndrome Symptoms
This systematic review examines how acupuncture influences the microbiota-gut-brain axis in patients with irritable bowel syndrome. The auth…
New research suggests acupuncture may help manage irritable bowel syndrome by improving gut bacteria and balancing the gut-brain connection.
Reduced Shannon index indicates lower alpha-diversity in the gut microbiota of patients with primary biliary cholangitis
Gut Microbiota Differences Linked to Primary Biliary Cholangitis
This meta-analysis of 1,057 participants found that patients with primary biliary cholangitis have significantly lower Shannon index values …
A large review of patient data shows that people with primary biliary cholangitis have significantly lower gut bacterial diversity than heal…
Probiotic supplementation may improve salivary buffering and reduce cariogenic bacteria
A review of six studies shows probiotics may help oral and gut health in people
This systematic review of 6 reviews suggests probiotic supplementation may improve salivary buffering capacity and plaque pH, reduce Strepto…
This review looked at six studies on probiotic supplements. Results suggest better saliva function and fewer bad mouth bacteria, though stud…
Balloon-assisted ESD shows comparable outcomes to conventional ESD for colorectal polyps
Balloon-assisted endoscopic submucosal dissection shows shorter procedure time in RCTs
This systematic review and meta-analysis of 1449 patients found that balloon-assisted endoscopic submucosal dissection (BA-ESD) and conventi…
A meta-analysis of 1,449 patients found balloon-assisted endoscopic submucosal dissection had shorter procedure times in randomized trials, …
From Other Specialties
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Heterogeneous definitions and clinical inconsistencies currently hinder the accurate identification of treatment-resistant depression
New ways to define treatment resistant depression are emerging
This narrative review examines the phenotypic definition of treatment-resistant depression (TRD) and its associated biological correlates. T…
Doctors struggle to treat some types of depression because the current definition is inconsistent. New research looks at how biology and beh…
HIFU combined with ethanol ablation or GnRH-a improves intraoperative outcomes for adenomyosis treatment
HIFU Combined With Medication Shows Better Results for Adenomyosis
This network meta-analysis of 1,685 patients evaluated HIFU combined with various medications compared to HIFU alone for adenomyosis. The an…
Combining high-intensity focused ultrasound (HIFU) with specific medications may improve treatment outcomes for people with adenomyosis.
Risk-optimized use of Janus kinase inhibitors in Japanese patients with rheumatoid arthritis depends on comorbidities
New evidence helps doctors choose safer arthritis treatments for seniors
This narrative review examines the safety and risk profile of Janus kinase inhibitors (JAKi) for rheumatoid arthritis specifically within th…
Doctors are moving toward personalized plans for rheumatoid arthritis, focusing on a patient's specific health risks rather than just their …